| scholarly article | Q13442814 |
| P50 | author | Kip M. Connor | Q40460422 |
| Magali Saint-Geniez | Q58898025 | ||
| P2093 | author name string | Alexandra Castillejos | |
| Clifford Kim | |||
| Daniel Diaz-Aguilar | |||
| Kaylee E Smith | |||
| P2860 | cites work | Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 | Q24316075 |
| Complement. First of two parts | Q28210663 | ||
| Complement. Second of two parts | Q28211878 | ||
| Complement: a key system for immune surveillance and homeostasis | Q29615484 | ||
| The mouse retina as an angiogenesis model | Q30495106 | ||
| Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis | Q30542079 | ||
| The alternative complement pathway regulates pathological angiogenesis in the retina | Q33775122 | ||
| Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis | Q34374022 | ||
| Retinopathy of prematurity: molecular pathology and therapeutic strategies | Q35203783 | ||
| Vascular endothelial growth factor (VEGF) isoform regulation of early forebrain development. | Q35289571 | ||
| Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis | Q35817458 | ||
| Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators | Q35993096 | ||
| Antibody-mediated organ-allograft rejection | Q36263023 | ||
| Erythropoietin deficiency decreases vascular stability in mice. | Q36404124 | ||
| Cross-talk between the complement system and endothelial cells in physiologic conditions and in vascular diseases | Q36573005 | ||
| The alternative complement pathway revisited | Q37141297 | ||
| Neurodegeneration in the pathogenesis of diabetic retinopathy: molecular mechanisms and therapeutic implications | Q38112711 | ||
| Inhibition of tumor necrosis factor-alpha improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy. | Q38585255 | ||
| Molecular and functional analysis of mouse decay accelerating factor (CD55) | Q41808735 | ||
| The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9 | Q45074903 | ||
| Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity | Q47629197 | ||
| A targeted disruption of the murine complement factor B gene resulting in loss of expression of three genes in close proximity, factor B, C2, and D17H6S45. | Q52528752 | ||
| Regulatory control of the terminal complement proteins at the surface of human endothelial cells: neutralization of a C5b-9 inhibitor by antibody to CD59 | Q67678006 | ||
| Retinopathy of prematurity | Q68206886 | ||
| Oxygen-induced retinopathy in the mouse | Q71608431 | ||
| Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor | Q73226153 | ||
| The multicenter study of Early Treatment for Retinopathy of Prematurity (ETROP) | Q73947100 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | murine model | Q122890741 |
| P304 | page(s) | 1300-1305 | |
| P577 | publication date | 2015-11-30 | |
| P1433 | published in | FASEB Journal | Q520194 |
| P1476 | title | The alternative complement pathway aids in vascular regression during the early stages of a murine model of proliferative retinopathy | |
| P478 | volume | 30 |
| Q41423380 | Genome-wide expression differences in anti-Vegf and dexamethasone treatment of inflammatory angiogenesis in the rat cornea. |
| Q59137366 | New insight into the role of the complement in the most common types of retinopathy-current literature review |
| Q58769421 | The Alternative Complement System Mediates Cell Death in Retinal Ischemia Reperfusion Injury |
| Q64905140 | The Challenges and Promise of Complement Therapeutics for Ocular Diseases. |
| Q51766201 | The Complement System Is Critical in Maintaining Retinal Integrity during Aging. |
| Q89787619 | Toll-like Receptor 2 Facilitates Oxidative Damage-Induced Retinal Degeneration |
Search more.